Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Leonhard Mohr"'
Autor:
E. Walter, Winfried V. Kern, Hans Christian Spangenberg, Gerhild Becker, Fritz von Weizsäcker, Robert Thimme, Roman Huber, Thomas Baumert, Peter Hafkemeyer, Christian N. Arnold, Leonhard Mohr, Michael Geißler, S Offensperger, Markus H. Heim, Darius Moradpour, W.-B. Offensperger, Hans-Peter Allgaier, Jan Harder
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 143:40-45
Autor:
Hans-Peter, Allgaier, Christian, Arnold, Thomas F, Baumert, Gerhild, Becker, Michael, Geißler, Peter, Hafkemeyer, Jan, Harder, Markus H, Heim, Roman, Huber, Winfried V, Kern, Leonhard, Mohr, Darius, Moradpour, Silke, Offensperger, Wolf-Bernhard, Offensperger, Hans Christian, Spangenberg, Robert, Thimme, Eike, Walter, Fritz, von Weizsäcker
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 143(1)
Autor:
C.F. Grimm, Hubert E. Blum, Jesús Prieto, María Matilde Bartolomé Rodríguez, Cheng Qian, Michael Geissler, Seung-Min Ryu, Leonhard Mohr
Publikováno v:
Human Gene Therapy. 19:753-759
Most hepatocellular carcinomas (HCCs) express oncofetal alpha-fetoprotein (AFP). We and others have demonstrated efficient tumor control mediated by cellular immune responses in mice bearing subcutaneous tumors derived from the AFP-expressing murine
Autor:
Jens Timmer, Leonhard Mohr, Clemens Kreutz, M. Seidl, Thomas Maiwald, Hubert E. Blum, M.M. Bartolome Rodriguez
Publikováno v:
Bioinformatics. 23:2747-2753
Motivation: Quantitative experimental data is the critical bottleneck in the modeling of dynamic cellular processes in systems biology. Here, we present statistical approaches improving reproducibility of protein quantification by immunoprecipitation
Publikováno v:
Zentralblatt für Chirurgie. 132:322-327
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in some areas of the world. The prognosis of HCC patients is generally very poor with a 5-year survival rate of less than 5%. Therapeutic strategies include surgery (resection
Autor:
Hubert E. Blum, Wulf O. Böcher, Michael Geissler, Robert Weth, Marcus Ritter, Leonhard Mohr, M. Ali, C.F. Grimm, Hans-Peter Allgaier, Katja Endrulat
Publikováno v:
Journal of Hepatology. 43:817-822
Background/Aims Local ablation methods are an effective treatment for hepatocellular carcinoma (HCC). The rate of recurrence or development of intra-hepatic metastases may be lowered by antitumoral immune responses. Since HCCs are in general only wea
Publikováno v:
Der Klinikarzt. 34:273-278
Autor:
Katja Endrulat, Robert Weth, Wulf O. Böcher, Michael Geissler, Heiner Wedemeyer, Leonhard Mohr, Hubert E. Blum, C.F. Grimm, M. Ali, Marcus Ritter
Publikováno v:
Journal of Hepatology. 41:999-1007
Background/Aims Novel immunotherapeutic and other strategies are being explored for the treatment of hepatocellular carcinoma (HCC). Alpha-fetoprotein (AFP) may be a target antigen for immunotherapy. Little is known, however, about the immunobiology
Publikováno v:
Expert Opinion on Biological Therapy. 2:163-175
For most patients with advanced or multifocal hepatocellular carcinoma (HCC) or with metastatic malignant liver disease treatment options are limited, resulting in a poor prognosis. Novel therapeutic strategies such as gene therapy are therefore urge
Publikováno v:
Cancer Gene Therapy. 8:573-579
Gene therapy may become an option for the treatment of malignant tumors such as hepatocellular carcinoma (HCC), once safe and efficient vector systems have been established. Due to their stability in vivo , recombinant adenoviral vectors are promisin